Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Lexaria Bioscience (LEXX) Long-Term Debt Repayments (2016 - 2021)

Historic Long-Term Debt Repayments for Lexaria Bioscience (LEXX) over the last 4 years, with Q3 2021 value amounting to -$419.0.

  • Lexaria Bioscience's Long-Term Debt Repayments changed N/A to -$419.0 in Q3 2021 from the same period last year, while for Aug 2022 it was -$419.0, marking a year-over-year decrease of 10044.3%. This contributed to the annual value of $22744.0 for FY2021, which is N/A changed from last year.
  • Per Lexaria Bioscience's latest filing, its Long-Term Debt Repayments stood at -$419.0 for Q3 2021.
  • Over the past 5 years, Lexaria Bioscience's Long-Term Debt Repayments peaked at -$419.0 during Q3 2021, and registered a low of -$419.0 during Q3 2021.